Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Sensitivity, Specificity, and Predicted Value

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...

Prediction Intervals

Prediction Intervals

The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessing the trustworthiness of health guidelines recommendations: the transparent, rigorous, useable, standardized, and trustworthy guide (TRUSTGUIDES) tools development.

Journal of clinical epidemiology·2026

Same author

Towards global clinical practice guidelines for the management of non-specific low back pain in primary care: a review of current guideline recommendations and how they have changed over the last 30 years.

The Lancet. Rheumatology·2026

Same author

Outcome domains of patient-reported outcome measures used in randomised controlled trials for older adults with non-specific low back pain: a systematic review.

Age and ageing·2026

Same author

Prognostic Factors of High Healthcare Utilization Costs Among People With Spinal Disorders Using a Spine Registry Linked to Public Healthcare Data.

European journal of pain (London, England)·2026

Same author

Development of a Central Sensitization Inventory short form using data from twenty-three countries.

The journal of pain·2026

Same author

Challenges in conducting an individual participant data meta-analysis of non-steroidal anti-inflammatory drugs for patients with (sub)acute low back pain: a systematic review and report on data availability.

BMJ open·2026

Search research articles

Related Experiment Video

Updated: Apr 2, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

When Is a Prognostic Prediction Model Ready for Clinical Use? A Primer for Clinicians.

Daniel Feller, Alessandro Chiarotto

The Journal of Orthopaedic and Sports Physical Therapy

|April 1, 2026

Summary

Clinicians must rigorously evaluate prognostic prediction models for clinical use. Validation, performance assessment, and bias evaluation ensure reliable patient prognosis and informed decision-making.

Keywords:

PROBAST+AI artificial intelligence musculoskeletal disorders predictive models

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Related Experiment Videos

Last Updated: Apr 2, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

An R-Based Landscape Validation of a Competing Risk Model

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

Clinical Epidemiology
Biostatistics
Health Informatics

Background:

Accurate prognosis is vital for clinical decision-making.
Prognostic prediction models aid individualized predictions but need careful evaluation.
Models developed in one dataset may not perform well in new patient data.

Purpose of the Study:

To outline a structured process for clinicians to determine the readiness of prognostic prediction models for routine practice.
To emphasize the critical need for methodological evaluation before clinical implementation.

Main Methods:

Prognostic models utilize regression or machine learning to combine variables for outcome prediction.
Evaluation involves internal/external validation, performance assessment (discrimination, calibration, clinical utility), and bias risk appraisal.
Effectiveness studies are necessary to confirm improved patient outcomes.

Main Results:

Model performance in development datasets does not guarantee real-world effectiveness.
Rigorous validation and bias assessment are crucial for reliability.
Clinical utility and impact on patient outcomes must be verified.

Conclusions:

Clinicians should adopt a structured review process for prognostic models.
Models must demonstrate validation in the target population, strong performance metrics, and minimal bias risk.
Only models meeting these standards are suitable for clinical adoption.